Aosaikang shareholder's stake dips below 12% after major sale

Jiangsu Suyang Investment Co., Ltd. (Suyang Investment), a major shareholder in Beijing Aosaikang Pharmaceutical Co., Ltd., has reduced its holding by 9,281,600 shares, representing 1.00% of the company's total share capital. The transactions occurred between September 15, 2025, and November 10, 2025, via concentrated bidding and block trading methods to meet its operational development needs.

Prior to this adjustment, Suyang Investment held 119,782,160 shares, or 12.91% of Beijing Aosaikang Pharmaceutical's total share capital. Following the sale, its ownership decreased to 110,500,560 shares, bringing its stake to 11.91%. This change in shareholding met the 1% disclosure threshold.

The company confirmed that the share reduction by Suyang Investment aligns with a previously disclosed plan and will not result in a change of control or have a significant impact on the company's operations. The plan is still in progress, and no violations of securities laws or regulations have been identified.